ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
This brief describes typical assets that make up an equal weighted index and how diverse holdings contribute to balanced exposure and performance.
17,287 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Buffett’s moves often spark debates about dividend stocks. This article digs into the idea behind 'warren buffett own...
The Federal Reserve Bank Minneapolis signals ongoing inflation uncertainty, stressing that price gains are easing but...
EWZ’s semi-annual payouts are highly dependent on Petrobras and Vale, delivering big checks in buoyant commodity mark...
The 2027 COLA estimate has jumped to 3.2% from 1.2%, aided by March inflation and higher energy prices. Retirees face...
Goldman Sachs researchers contend that the U.S. labor market has improved since ChatGPT first opened its chat window,...
As Nasdaq volatility surges amid broader market jitters, one sub-$20 tech stock with a near-monopoly in a niche data ...
April data show 4.4 months of housing supply, up from March as inventory grows. Buyers face higher rates and remote m...
Goldman Sachs’ weekly briefing shows hedge funds trimming software exposure while piling into semiconductors, signali...
SpaceX plans a record-breaking IPO, but the bulk of proceeds is already spoken for. Analysts warn the small public fl...
A fresh BEA release shows the U.S. consumer draining savings while income grows slowly, signaling trouble ahead for g...
Markets paused their march higher at midday as tech leadership shines and geopolitical headwinds test appetite. Marve...